Coya Therapeutics (COYA) Operating Income (2023 - 2025)
Historic Operating Income for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$2.4 million.
- Coya Therapeutics' Operating Income rose 4533.17% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.6 million, marking a year-over-year decrease of 8147.05%. This contributed to the annual value of -$17.2 million for FY2024, which is 11825.82% down from last year.
- Per Coya Therapeutics' latest filing, its Operating Income stood at -$2.4 million for Q3 2025, which was up 4533.17% from -$6.4 million recorded in Q2 2025.
- In the past 5 years, Coya Therapeutics' Operating Income registered a high of $1.8 million during Q4 2023, and its lowest value of -$7.7 million during Q1 2025.
- Its 3-year average for Operating Income is -$3.8 million, with a median of -$3.6 million in 2023.
- In the last 5 years, Coya Therapeutics' Operating Income crashed by 32479.04% in 2024 and then soared by 4533.17% in 2025.
- Quarter analysis of 3 years shows Coya Therapeutics' Operating Income stood at $1.8 million in 2023, then crashed by 324.79% to -$4.1 million in 2024, then surged by 40.37% to -$2.4 million in 2025.
- Its Operating Income stands at -$2.4 million for Q3 2025, versus -$6.4 million for Q2 2025 and -$7.7 million for Q1 2025.